Small endostatin derivatives prepared using genetic engineering techniques, and cancer treatments containing the same as active ingredients

摘要

The present invention is composed of 103 amino acids from which N-terminal 30 amino acids and C-terminal 50 amino acids of endostatin are derived from endostatin by genetic recombination technology, and glutathione esterase in the N-terminal region is The present invention relates to a linked small endostatin derivative and a cancer therapeutic agent containing the derivative as an active ingredient.